CytoDyn (OTCMKTS: CYDY) investors waking up to the news of the departure of long term CEO and director Nader Pourhassan are probably...
CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
CytoDyn Inc (OTCMKTS: CYDY) stock has posted impressive gains ever since the biotechnology company posted preclinical data showing its candidate dr...